Surgery Partners

Surgery Partners, Inc. is healthcare services holding company, which engages in the provision of solutions for surgical and related ancillary care in support of its patients and physicians. It operates through the following business segments: Surgical Facility Services, Ancillary Services, and Optical Services. The Surgical Facility Services segment consists of the operation of ambulatory surgery centers and surgical hospitals, including anesthesia services of the company. The Ancillary Services segment operates a diagnostic laboratory and multi-specialty physician practices. The Optical Services segment involves an optical laboratory and an optical products group purchasing organization. The company was founded in 2004 and is headquartered in Brentwood, TN.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Surgery Partners reports robust Q4 earnings, eyes growth in cardiac care

Surgery Partners' strong financial performance, driven by strategic initiatives and revenue growth, positions the company for continued success. While facing challenges in adoption rates and reimbursement, the company's focus on outpatient care and higher acuity service lines presents growth opportunities. With a proactive approach to recruitment and expansion, Surgery Partners is poised for a positive trajectory in 2023.

Surgery Partners (SGRY) posts robust Q1 results, eyes strategic growth

Surgery Partners (SGRY) delivered strong financial performance, operational efficiency, and strategic growth initiatives in Q1 2023.
Despite challenges from revenue timing and minimal earnings impact in the short term, the company's disciplined approach and focus on partnerships and acquisitions offer promising opportunities.
With a raised adjusted EBITDA outlook, a commitment to excellence, and a clear growth strategy, Surgery Partners is well-positioned for continued success and value creation.

Surgery Partners exceeds Q2 expectations, eyes strategic growth opportunities

Surgery Partners delivered strong financial performance in Q2 2023, surpassing expectations and demonstrating resilience in surgical case growth.
Despite challenges in anesthesia coverage and subsidies, the company remains optimistic about its growth prospects and is focused on operational efficiencies.
Strategic investments in orthopedics and cardiology, along with a commitment to high-quality care, underscore Surgery Partners' long-term growth potential.

Surgery Partners beats Q3 targets, eyes mid-teens growth in 2024

Surgery Partners exceeded Q3 expectations, showcasing strong performance and strategic initiatives. While facing challenges from portfolio adjustments and regulatory proposals, the company is well-positioned for continued growth through acquisitions and focus on high acuity cases.

Surgery Partners (SGRY) reports robust 2023 results and eyes strategic growth in 2024

Surgery Partners (SGRY) delivered strong financial performance in 2023, with a positive outlook for 2024. The company's focus on margin expansion, growth in higher acuity procedures, and strategic acquisitions positions it well for continued success. Challenges include cash flow uncertainties and the impact of unique comp dynamics on case growth.

Surgery Partners (SGRY) reports robust Q1 earnings and eyes strategic acquisitions for continued growth

Surgery Partners (SGRY) delivered strong financial results in Q1 2024, showcasing solid revenue growth and margin expansion. The company's strategic focus on acquisitions, margin improvement initiatives, and effective cost management underpin its optimistic outlook for sustained growth and cash flow generation.

Surgery Partners (SGRY) posts impressive Q2 results, raises full-year outlook

Surgery Partners (SGRY) delivered strong financial performance in Q2 2024, driven by revenue growth, enhanced margins, and strategic acquisitions. Despite facing leverage challenges, the company's focus on specialty physician recruitment and operational efficiency presents opportunities for sustained growth and profitability.

Surgery Partners posts strong Q3 results amidst Hurricane challenges

Surgery Partners demonstrated robust financial performance in Q3 2024, marked by revenue growth, margin expansion, and strategic acquisitions.
While facing challenges from Hurricane Helene, the company's focus on recruitment and growth in key specialties positions it well for future success.
With a strong outlook for the full year and a focus on high-growth markets and specialties, Surgery Partners shows resilience and strategic foresight.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Investors need to pay close attention to Surgery Partners (SGRY) stock based on the movements in the options market lately.

Are Options Traders Betting on a Big Move in Surgery Partners (SGRY) Stock?

Surgery Partners, Inc. (SGRY) CEO Eric Evans on Q3 2020 Results - Earnings Call Transcript

  Shares of Surgery Partners (NASDAQ:SGRY) decreased 0.3% in pre-market trading after the company reported Q3 results.

Surgery Partners: Q3 Earnings Insights

Surgery Partners (SGRY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Earnings Preview: Surgery Partners (SGRY) Q3 Earnings Expected to Decline

BRENTWOOD, Tenn., Oct. 21, 2020 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, announced the Company will release its third quarter 2020 results before the market opens on Wednesday, November 4, 2020, to be followed by a conference call at 8:30 a.m. (Eastern Time)

Surgery Partners, Inc. Announces Third Quarter 2020 Earnings Release Date and Conference Call Details

IRVING, Texas, Sept. 15, 2020 /PRNewswire/ -- NorthStar Anesthesia ("NorthStar" or the "Company"), one of the country's leading anesthesia care providers and managers, today announced that Anesthesia Consulting & Management, LP, has completed an acquisition of select anesthesia services.

NorthStar Anesthesia Completes Acquisition of Surgery Partners Anesthesia Services Business

Surgery Partners, Inc.'s (SGRY) CEO Eric Evans on Q2 2020 Results - Earnings Call Transcript

Surgery Partners (SGRY) delivered earnings and revenue surprises of 5.88% and 1.22%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

Surgery Partners (SGRY) Reports Q2 Loss, Tops Revenue Estimates

BRENTWOOD, Tenn., Aug.  05, 2020  (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, today announced results for the second quarter ended June 30, 2020.

Surgery Partners, Inc. Announces Second Quarter 2020 Results

Earnings Preview: Surgery Partners (SGRY) Q2 Earnings Expected to Decline

BRENTWOOD, Tenn., July  24, 2020  (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company") today announced that its wholly-owned subsidiary, Surgery Center Holdings, Inc. (the “Issuer”), priced $115.0 million aggregate principal amount of its 10.000% senior unsecured notes due 2027 (the “notes”) at 100.75% of the principal amount in a previously announced private offering exempt from the registration requirements of the Securities Act of 1933, as amended (the “Securities Act”). The offering is expected to close on July 30, 2020, subject to certain customary closing conditions. The notes will be guaranteed (the “guarantees”) on a senior unsecured basis by each domestic wholly-owned subsidiary of the Issuer that guarantees the Issuer’s obligations under its senior secured credit facilities. The notes will be issued as part of the same series as the $430 million of 10.000% senior notes due 2027 originally issued in April 2019.

Surgery Partners, Inc. Announces Pricing of Incremental Note Offering

BRENTWOOD, Tenn., July  21, 2020  (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, announced the Company will release its second quarter 2020 results before the market opens on Wednesday, August 5, 2020, to be followed by a conference call at 8:30 a.m. (Eastern Time)

Surgery Partners, Inc. Announces Second Quarter 2020 Earnings Release Date and Conference Call Details

Surgery Partners, Inc. (SGRY) CEO Eric Evans on Q1 2020 Results - Earnings Call Transcript

Surgery Partners, Inc. (SGRY) CEO Eric Evans on Q4 2019 Results - Earnings Call Transcript

Surgery Partners (SGRY) delivered earnings and revenue surprises of -16.67% and 2.60%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

Surgery Partners (SGRY) Q4 Earnings Lag Estimates

Does Surgery Partners (SGRY) have what it takes to be a top stock pick for momentum investors? Let's find out.

Are You Looking for a Top Momentum Pick? Why Surgery Partners (SGRY) is a Great Choice

Wayne S. DeVeydt appointed to Executive Chairman of the Board  Eric Evans appointed to Chief Executive Officer  Company reaffirms 2019 full year guidance of double-digit Adjusted EBITDA growth

Surgery Partners, Inc. Announces Executive Promotions

Surgery Partners is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.

Moving Average Crossover Alert: Surgery Partners

As of late, it has definitely been a great time to be an investor in Surgery Partners.

Will Surgery Partners Continue to Surge Higher?

Surgery Partners, Inc. (SGRY) CEO Wayne DeVeydt on Q3 2019 Results - Earnings Call Transcript

EVP & COO of Surgery Partners Inc (30-Year Financial, Insider Trades) Jason Eric Evans (insider trades) bought 25,000 shares of SGRY on 08/20/2019 at an average price of $5.95 a share.

Surgery Partners Inc (SGRY) EVP & COO Jason Eric Evans Bought $148,750 of Shares

Surgery Partners, Inc. (SGRY) CEO Wayne DeVeydt on Q2 2019 Results - Earnings Call Transcript

Surgery Partners (SGRY) delivered earnings and revenue surprises of -70.59% and -0.93%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

Surgery Partners (SGRY) Reports Q2 Loss, Lags Revenue Estimates

Surgery Partners, Inc. (SGRY) CEO Wayne DeVeydt on Q1 2019 Results - Earnings Call Transcript

News for Surgery Partners Stock (SGRY)